Imaging blood–brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky, L Kamintsky, I Noyman… - Brain, 2017 - academic.oup.com
A biomarker that will enable the identification of patients at high-risk for developing post-
injury epilepsy is critically required. Microvascular pathology and related blood–brain barrier …

Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.

G Bar-Klein, S Lublinsky, L Kamintsky… - Brain: a Journal of …, 2017 - europepmc.org
A biomarker that will enable the identification of patients at high-risk for developing post-
injury epilepsy is critically required. Microvascular pathology and related blood-brain barrier …

Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky… - Brain: a journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
A biomarker that will enable the identification of patients at high-risk for developing post-
injury epilepsy is critically required. Microvascular pathology and related blood-brain barrier …

[PDF][PDF] Imaging blood–brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky, L Kamintsky, I Noyman… - BRAIN, 2017 - academia.edu
In the field of brain protection and therapeutics, phase III clinical trials have repeatedly failed
to show therapeutic efficacy. This has necessitated a re-examination of translational …

Imaging blood–brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky, L Kamintsky, I Noyman… - Brain, 2017 - academic.oup.com
A biomarker that will enable the identification of patients at high-risk for developing post-
injury epilepsy is critically required. Microvascular pathology and related blood–brain barrier …

Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky, L Kamintsky, I Noyman… - Brain, 2017 - cris.bgu.ac.il
A biomarker that will enable the identification of patients at high-risk for developing post-
injury epilepsy is critically required. Microvascular pathology and related blood-brain barrier …

[PDF][PDF] Imaging blood–brain barrier dysfunction as a biomarker for epileptogenesis

G Bar-Klein, S Lublinsky, L Kamintsky, I Noyman… - BRAIN, 2017 - academia.edu
In the field of brain protection and therapeutics, phase III clinical trials have repeatedly failed
to show therapeutic efficacy. This has necessitated a re-examination of translational …